News
Glenmark announces the Discovery of a novel chemical entity...
Glenmark Pharmaceuticals announced the discovery of a Novel Chemical Entity(NCE) 'GRC 17536'. The new NCE program is targeting TRPA1 recept or antagonists for pain and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.